Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2020 1
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
Ferrucci V, Kong DY, Asadzadeh F, Marrone L, Boccia A, Siciliano R, Criscuolo G, Anastasio C, Quarantelli F, Comegna M, Pisano I, Passariello M, Iacobucci I, Monica RD, Izzo B, Cerino P, Fusco G, Viscardi M, Brandi S, Pierri BM, Borriello G, Tiberio C, Atripaldi L, Bianchi M, Paolella G, Capoluongo E, Castaldo G, Chiariotti L, Monti M, De Lorenzo C, Yun KS, Pascarella S, Cheong JH, Kim HY, Zollo M. Ferrucci V, et al. Among authors: quarantelli f. Sci Signal. 2021 Jul 6;14(690):eabe5040. doi: 10.1126/scisignal.abe5040. Sci Signal. 2021. PMID: 34230209 Free PMC article.
Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients-A Target for SARS-CoV-2 Propagation.
Ferrucci V, de Antonellis P, Quarantelli F, Asadzadeh F, Bibbò F, Siciliano R, Sorice C, Pisano I, Izzo B, Di Domenico C, Boccia A, Vargas M, Pierri B, Viscardi M, Brandi S, Fusco G, Cerino P, De Pietro L, Furfaro C, Napolitano LA, Paolella G, Festa L, Marzinotto S, Conte MC, Gentile I, Servillo G, Curcio F, de Cristofaro T, Broccolo F, Capoluongo E, Zollo M. Ferrucci V, et al. Among authors: quarantelli f. Int J Mol Sci. 2022 Feb 9;23(4):1941. doi: 10.3390/ijms23041941. Int J Mol Sci. 2022. PMID: 35216056 Free PMC article.
Identification of SARS-CoV-2 Proteins from Nasopharyngeal Swabs Probed by Multiple Reaction Monitoring Tandem Mass Spectrometry.
Pinto G, Illiano A, Ferrucci V, Quarantelli F, Fontanarosa C, Siciliano R, Di Domenico C, Izzo B, Pucci P, Marino G, Zollo M, Amoresano A. Pinto G, et al. Among authors: quarantelli f. ACS Omega. 2021 Dec 7;6(50):34945-34953. doi: 10.1021/acsomega.1c05587. eCollection 2021 Dec 21. ACS Omega. 2021. PMID: 34926968 Free PMC article.
SARS-CoV-2 Subgenomic N (sgN) Transcripts in Oro-Nasopharyngeal Swabs Correlate with the Highest Viral Load, as Evaluated by Five Different Molecular Methods.
Zollo M, Ferrucci V, Izzo B, Quarantelli F, Domenico CD, Comegna M, Paolillo C, Amato F, Siciliano R, Castaldo G, Capoluongo E. Zollo M, et al. Among authors: quarantelli f. Diagnostics (Basel). 2021 Feb 12;11(2):288. doi: 10.3390/diagnostics11020288. Diagnostics (Basel). 2021. PMID: 33673182 Free PMC article.
Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts.
Petiti J, Lo Iacono M, Dragani M, Pironi L, Fantino C, Rapanotti MC, Quarantelli F, Izzo B, Divona M, Rege-Cambrin G, Saglio G, Gottardi EM, Cilloni D, Fava C. Petiti J, et al. Among authors: quarantelli f. J Clin Med. 2020 May 13;9(5):1457. doi: 10.3390/jcm9051457. J Clin Med. 2020. PMID: 32414125 Free PMC article.
Long-term molecular responses to imatinib in patients with chronic myeloid leukemia: comparison between complete cytogenetic responders treated in early and in late chronic phase.
Palandri F, Iacobucci I, Quarantelli F, Castagnetti F, Cilloni D, Baccarani M; GIMEMA Working Party on CML. Palandri F, et al. Among authors: quarantelli f. Haematologica. 2007 Nov;92(11):1579-80. doi: 10.3324/haematol.12033. Haematologica. 2007. PMID: 18024412 Free article. Clinical Trial.
Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate.
Alimena G, Breccia M, Luciano L, Quarantelli F, Diverio D, Izzo B, De Angelis B, Mancini M, Latagliata R, Carmosino I, Nanni M, Picardi M, Rotoli B, Mandelli F, Pane F. Alimena G, et al. Among authors: quarantelli f. Leuk Res. 2008 Feb;32(2):255-61. doi: 10.1016/j.leukres.2007.06.008. Epub 2007 Aug 10. Leuk Res. 2008. PMID: 17692911 Clinical Trial.